Fluoxetine (Lilly 110140) HCl

Catalog No.S1333

For research use only.

Fluoxetine HCl (Lilly110140) is a selective serotonin-reuptake inhibitor (SSRI) at the neuronal membrane, used in the treatment of depression.

Fluoxetine (Lilly 110140) HCl Chemical Structure

CAS No. 56296-78-7

Selleck's Fluoxetine (Lilly 110140) HCl has been cited by 15 publications

Purity & Quality Control

Choose Selective 5-HT Receptor Inhibitors

Other 5-HT Receptor Products

Biological Activity

Description Fluoxetine HCl (Lilly110140) is a selective serotonin-reuptake inhibitor (SSRI) at the neuronal membrane, used in the treatment of depression.
Targets
5-HT [1]
In vitro

Fluoxetine blocks the downregulation of cell proliferation resulting from inescapable shock (IS) of hippocampal cell. [1] Fluoxetine increases the number of newborn cells in the dentate gyrus of the hippocampus of adult rat. Fluoxetine also increases the number of proliferating cells in the prelimbic cortex. [2] Fluoxetine accelerates the maturation of immature neurons. Fluoxetine enhances neurogenesis-dependent long-term potentiation (LTP) in the dentate gyrus. [3] Fluoxetine, but not citalopram, fluvoxamine, paroxetine and sertraline, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Fluoxetine produces robust and sustained increases in extracellular concentrations of norepinephrine and dopamine after acute systemic administration. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HEK293 NVrWOnpMTnWwY4Tpc44h[XO|YYm= Mo\oN|AhdWmwcx?= MYPJcohq[mm2aX;uJI9nKGi3bXHuJHNGWlRiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHOncn;0c45qdiC{ZYXweIFs\SCjZoTldkA{OCCvaX7zJIJ6KG[udX;y[ZNk\W6lZTDhd5NigSxiSVO1NF0xNjF3zszN NGrvS4E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkmzPFA1QSd-MkK5N|gxPDl:L3G+
HEK293 M3jscmZ2dmO2aX;uJIF{e2G7 MnXYN|AhdWmwcx?= MV7Jcohq[mm2aX;uJI9nKGi3bXHuJG5GXCCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4Yhdm:{YXTy[Y5idGmwZTDy[ZVxfGGtZTDh[pRmeiB|MDDtbY5{KGK7IH\seY9z\XOlZX7j[UBie3OjeTygTWM2OD12LkSx{txO M{jLOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OUO4NFQ6Lz5{MkmzPFA1QTxxYU6=
HEK293 MkLiSpVv[3Srb36gZZN{[Xl? MoPKN|AhdWmwcx?= NHjZZ5VKdmirYnn0bY9vKG:oIHj1cYFvKESDVDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiZH;wZY1qdmVicnX1dJRic2ViYX\0[ZIhOzBibXnud{BjgSCobIXvdoV{[2WwY3WgZZN{[XluIFnDOVA:OThwNN88US=> NIWwWXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkmzPFA1QSd-MkK5N|gxPDl:L3G+
mammalian cells NWDwUJFwTnWwY4Tpc44h[XO|YYm= MVrJcohq[mm2aX;uJI9nKGi3bXHuJHBwfGG|c3n1cUBkcGGwbnXsJGhGWkdiZYjwdoV{e2WmIHnuJI1idW2jbHnhckBk\WyuczygTWM2OD1zLkWxN|U3|ryP MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOjh5M{WxNkc,OTJ6N{O1NVI9N2F-
JAR NUK2b4tvTnWwY4Tpc44h[XO|YYm= MW\Jcohq[mm2aX;uJINwdmOnboTyZZRqd25iYXfhbY5{fCCdM1jdOU1JXCC3cIThb4Uh[nliaIXtZY4he2W{b4TvcolvKHS{YX7zdI9zfGW{IHnuJGpCWiClZXzsd{whUUN3ME2wMlA{OjUQvF2= M321fVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3MkO5OlYyLz5zNUKzPVY3OTxxYU6=
K562 NF7XW4ZEgXSxdH;4bYNqfHliYYPzZZk> NE\0PYtEgXSxdH;4bYNqfHlidH:gdoVlfWOnIHPodo9vcWNibYnlcI9q\CCuZYXr[Y1q[SCNIEW2NkBk\WyuczygR2M2OD1{Nd88US=> NEDjdJg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUK2O|IzQSd-MUWyOlczOjl:L3G+
U937 NUm4UHdlS3m2b4TvfIlkcXS7IHHzd4F6 MWHDfZRwfG:6aXPpeJkhfG9icnXkeYNmKGi3bXHuJIhqe3SxbIn0bYMhdHmvcHjvcYEhXTl|NzDj[YxteyxiQ1O1NF0{Oy5|zszN MoW1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV{NkeyNlkoRjF3Mk[3NlI6RC:jPh?=
HEK293 MXLGeY5kfGmxbjDhd5NigQ>? M3rGZ2lvcGmkaYTpc44hd2ZiW{PIYVUuUFRidYD0ZYtmKGG2IEXIWEB1emGwc4DvdpRmeiCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{NCCLQ{WwQVAvODF4zszN NVrZToF4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[3OVA{PTlpPkG2O|UxOzV7PD;hQi=>
HEK293 MoHISpVv[3Srb36gZZN{[Xl? NHLZfnRKdmirYnn0bY9vKG:oIFTBJJRz[W6|cH;yeIVzKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMtKEmFNUC9OE41|ryP NILpfJE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNke1NFM2QSd-MU[3OVA{PTl:L3G+
HEK293 NWPkUFRXTnWwY4Tpc44h[XO|YYm= MYPJcohq[mm2aX;uJI9nKFt|SG3ORUB2eHSja3WgZZQhVkFidILhcpNxd3K2ZYKg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczygTWM2OD13LkNOwG0> NInLbJE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNke1NFM2QSd-MU[3OVA{PTl:L3G+
HEK293 NYiyeJJoTnWwY4Tpc44h[XO|YYm= MmG0TY5pcWKrdHnvckBw\iCdM1jdOU1JXCC{ZYXweIFs\SCjdDC1THQhfHKjboPwc5J1\XJiaX6gTGVMOjl|IHPlcIx{NCCLQ{WwQVAvODF4zszN NG\ORok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNke1NFM3Oyd-MU[3OVA{PjN:L3G+
HEK293 MWfGeY5kfGmxbjDhd5NigQ>? NECzPYZKdmirYnn0bY9vKG:oIGuzTH1FSSC{ZYXweIFs\SCjdDDERUB1emGwc4DvdpRmeiCrbjDISWszQTNiY3XscJMtKEmFNUC9OE41|ryP MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPjd3MEO2N{c,OTZ5NUCzOlM9N2F-
HEK293 NX\NR457TnWwY4Tpc44h[XO|YYm= MW\Jcohq[mm2aX;uJI9nKFt|SG3ORUBz\XWydHHr[UBifCCQQTD0doFve3CxcoTldkBqdiCKRVuyPVMh[2WubIOsJGlEPTB;NT6y{txO M1XkdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF4N{WwN|Y{Lz5zNke1NFM3OzxxYU6=
Jar NFLxfmJHfW6ldHnvckBie3OjeR?= MnXmTY5pcWKrdHnvckBw\iCdM1jdOU1JXCC3cIThb4Uh[XRiaIXtZY4hPS2KVDD0doFve3CxcoTldkBmgHC{ZYPz[YQhcW5iSnHyJINmdGy|LDDJR|UxRTBwMEO5OO69VQ>? NYjVc|ZVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[4OVQxQDZpPkG2PFU1ODh4PD;hQi=>
SK-N-MC MVfGeY5kfGmxbjDhd5NigQ>? NI\OVFlFcXOybHHj[Y1mdnRib3[gUk1cO0ifYXzwbIEudWW2aInsbIl{fGGvaX7lJIZzd21iaIXtZY4hcGm|dHHtbY5mKEh|IILlZ4VxfG:{IHX4dJJme3OnZDDpckBUUy2QLV3DJINmdGy|LDDLbV04NjQQvF2= M1u0cVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5M{C3N|U5Lz5zN{OwO|M2QDxxYU6=
CHO M3zxfWZ2dmO2aX;uJIF{e2G7 NXvifXVQUW6qaXLpeIlwdiCxZjDoeY1idiCHUleg[ZhxemW|c3XkJIlvKEOKTzDj[YxteyCkeTD3bI9t\SClZXzsJJBifGOqIHPsZY1xKHSnY3jubZF2\SxiSVO1NF0yNjVzM{W2{txO NHzFXW49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOES0PFM1Oid-MUi0OFg{PDJ:L3G+
HEK293 NF;zbHFHfW6ldHnvckBie3OjeR?= NGLxS5ZKdmirYnn0bY9vKG:oIIPldo91d26rbjD1dJRic2ViYYSgbJVu[W5iU1XSWEBqdiCqdX3hckBJTUt{OUOgZ4VtdHNuIFnDOVA:OC5yNEhOwG0> MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDV3MEO2PUc,OTh3NUCzOlk9N2F-
HEK293 MUXGeY5kfGmxbjDhd5NigQ>? NUPqOZJoUW6qaXLpeIlwdiCxZjDuc5JmeGmwZYDodolv\SC3cIThb4Uh[XRiaIXtZY4hVkWWIHnuJIh2dWGwIFjFT|I6OyClZXzsd{whUUN3ME2y{txO MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDV3MEO2PUc,OTh3NUCzOlk9N2F-
HEK293 NX36XGtQTnWwY4Tpc44h[XO|YYm= NVT4bIVSUW6qaXLpeIlwdiCxZjDkc5BidWmwZTD1dJRic2ViYYSgbJVu[W5iRFHUJIlvKGi3bXHuJGhGUzJ7MzDj[YxteyxiSVO1NF03|ryP NWWwTmszRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVA{PjlpPkG4OVUxOzZ7PD;hQi=>
JAR M3LHd2Z2dmO2aX;uJIF{e2G7 MVzJcohq[mm2aX;uJI9nKDWKVDD1dJRic2ViYYSgbJVu[W5iU1XSWEBmgHC{ZYPz[YQhcW5iaIXtZY4hUkGUIHPlcIx{NCCLQ{WwQVAvODB7NN88US=> MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDV3N{[wPEc,OTh3NUe2NFg9N2F-
HEK NXfSPJNZTnWwY4Tpc44h[XO|YYm= MVTJcohq[mm2aX;uJI9nKHOncn;0c45qdiC3cIThb4Uh[XRiaIXtZY4hW0WUVDDlfJBz\XO|ZXSgbY4hUEWNIHPlcIx{NCCLQ{WwQVAvODR5zszN MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDZ4N{OwPUc,OTh4NkezNFk9N2F-
HEK MWPGeY5kfGmxbjDhd5NigQ>? M3n0XWlvcGmkaYTpc44hd2Zibn;y[ZBqdmWyaILpcoUhfXC2YXvlJIF1KGi3bXHuJG5GXCCneIDy[ZN{\WRiaX6gTGVMKGOnbHzzMEBKSzVyPUNOwG0> NHz6dIQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOE[2O|MxQSd-MUi2Olc{ODl:L3G+
HEK NFixU49HfW6ldHnvckBie3OjeR?= NHzDVJZKdmirYnn0bY9vKG:oIHTvdIFucW6nIIXweIFs\SCjdDDoeY1idiCGQWSg[ZhxemW|c3XkJIlvKEiHSzDj[YxteyxiSVO1NF03|ryP MoHyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh4NkezNFkoRjF6Nk[3N|A6RC:jPh?=
JAR MmrJSpVv[3Srb36gZZN{[Xl? NGrVTIZKdmirYnn0bY9vKG:oIIPldo91d26rbjD1dJRic2ViYYSgbJVu[W5iU1XSWEBmgHC{ZYPz[YQhcW5iSlHSJINmdGy|LDDJR|UxRTBwMEJOwG0> MlTKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh5N{G5NVYoRjF6N{exPVE3RC:jPh?=
MDCK MVHGeY5kfGmxbjDhd5NigQ>? NGLJRpBKdmirYnn0bY9vKG:oIH7vdoVxcW6ncHjybY5mKHWydHHr[UBifCCqdX3hckBPTVRiZYjwdoV{e2WmIHnuJG1FS0tiY3XscJMtKEmFNUC9NE42PjQQvF2= Mmm0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh5N{G5NVYoRjF6N{exPVE3RC:jPh?=
Jar NGTOTJRHfW6ldHnvckBie3OjeR?= M1rhZmlvcGmkaYTpc44hd2ZiNT3IWEB1emGwc4DvdpRmei2vZXTpZZRm\CCdM1jdOWhVKHWydHHr[UBqdiCqdX3hckBL[XJiY3XscJMtKEmFNUC9NE4xOzl2zszN NU\z[oY6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi4N|QyQDhpPkG4PFM1OTh6PD;hQi=>
JAR MmXKSpVv[3Srb36gZZN{[Xl? MV;Jcohq[mm2aX;uJI9nKHOncn;0c45qdiC3cIThb4Uh[XRiaIXtZY4hW0WUVDDlfJBz\XO|ZXSgbY4hUkGUIHPlcIx{NCCLQ{WwQVAvODB7NN88US=> M2\CelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6OUWxNFIxLz5zOEm1NVAzODxxYU6=
HEK293 NEXLN2dHfW6ldHnvckBie3OjeR?= NITzSmxFcXOybHHj[Y1mdnRib3[gX|EzPUmfUmTJOVUh\nKxbTDoeY1idiC{ZXPvcYJqdmGwdDDTSXJVKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMtKEurPUCuNFAyOc7:TR?= MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTBzNEi4PEc,OTlyMUS4PFg9N2F-
HEK293 MlnjSpVv[3Srb36gZZN{[Xl? NIHufpdKdmirYnn0bY9vKG:oIGuzTH02UFRiZoLvcUBpfW2jbjDy[YNwdWKrbnHueEBUTVKWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNuIFnDOVA:OC5yMEhOwG0> NHPwcmE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUCxOFg5QCd-MUmwNVQ5QDh:L3G+
HEK293 MVrGeY5kfGmxbjDhd5NigQ>? M{LvbmlvcGmkaYTpc44hd2ZiW{PIYW5GKG[{b32gbJVu[W5icnXjc41jcW6jboSgUmVVKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMtKEmFNUC9NU4xOs7:TR?= MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTBzNEi4PEc,OTlyMUS4PFg9N2F-
HEK293 MmnJSpVv[3Srb36gZZN{[Xl? M4nITGRqe3CuYXPlcYVvfCCxZjDbNVI2UV2UVFm1OUBnem:vIHj1cYFvKHKnY3;tZolv[W62IF7FWEBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzMEBMcT1zLkW2{txO Mn\rQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlyMUS4PFgoRjF7MEG0PFg5RC:jPh?=
HEK293 MnHqSpVv[3Srb36gZZN{[Xl? MlLoSIl{eGyjY3Xt[Y51KG:oIGuxNlVKZVKWSUW1JIZzd21iaIXtZY4hemWlb33ibY5idnRiRFHUJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOsJGtqRTZwNkhOwG0> NYPMW5ZyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmwNVQ5QDhpPkG5NFE1QDh6PD;hQi=>
HEK293 NEjSeHJHfW6ldHnvckBie3OjeR?= MkPnTY5pcWKrdHnvckBw\iCdM1jdSGEh\nKxbTDoeY1idiC{ZXPvcYJqdmGwdDDERXQh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{whUUN3ME2xPU42|ryP MkSyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlyMUS4PFgoRjF7MEG0PFg5RC:jPh?=
HEK293 MYfGeY5kfGmxbjDhd5NigQ>? MmDISIl{eGyjY3Xt[Y51KG:oIGuxNlVKZVKWST21OUBnem:vIHj1cYFvKHKnY3;tZolv[W62IGPFVnQh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{BjgSC|Y3nueIltdGG2aX;uJINwfW62aX7nMEBMcT1yLkCwNVHPxE1? MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTJ3NkWwNkc,OTl{NU[1NFI9N2F-
HEK293 MUfGeY5kfGmxbjDhd5NigQ>? NX73NYJqTGm|cHzhZ4Vu\W62IH;mJHs{UF2|ZYLveI9vcW5iZoLvcUBpfW2jbjDy[YNwdWKrbnHueEBUTVKWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiYomgd4NqdnSrbHzheIlwdiClb4XueIlv\yxiSVO1NF0xNjByN{ROwG0> NI\JXWU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUK1OlUxOid-MUmyOVY2ODJ:L3G+
HEK293 NYrpZZJCTnWwY4Tpc44h[XO|YYm= NYL4d2hKTGm|cHzhZ4Vu\W62IH;mJHs{UF2wb4LldIlv\XCqcnnu[UBnem:vIHj1cYFvKHKnY3;tZolv[W62IF7FWEBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIJ6KHOlaX70bYxt[XSrb36gZ492dnSrbnesJGlEPTB;MT6wNu69VQ>? MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTJ3NkWwNkc,OTl{NU[1NFI9N2F-
HEK293 M4\wXmZ2dmO2aX;uJIF{e2G7 NITCO|dFcXOybHHj[Y1mdnRib3[gX|EzPUmfUmTJMVU2KG[{b32gbJVu[W5icnXjc41jcW6jboSgUmVVKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[nlic3PpcpRqdGyjdHnvckBkd3WwdHnu[{whU2l;MT61Ou69VQ>? NVGwZZJKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmyOVY2ODJpPkG5NlU3PTB{PD;hQi=>
HEK293 M1LzdWZ2dmO2aX;uJIF{e2G7 NULkSmhHTGm|cHzhZ4Vu\W62IH;mJHsyOjWLXWLUTU02PSCocn;tJIh2dWGwIILlZ49u[mmwYX70JGRCXCCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{KGK7IIPjbY51cWyuYYTpc44h[2:3boTpcoctKEurPU[uOlfPxE1? NXvTOIQ2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmyOVY2ODJpPkG5NlU3PTB{PD;hQi=>
HEK293 NYDuZ456TnWwY4Tpc44h[XO|YYm= MV7EbZNxdGGlZX3lcpQhd2ZiW{PIYYRweGGvaX7lJIZzd21iaIXtZY4hemWlb33ibY5idnRiRFHUJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZpkhe2OrboTpcIxifGmxbjDjc5VvfGmwZzygTWM2OD1zOT61{txO MnjjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl{NU[1NFIoRjF7MkW2OVAzRC:jPh?=
JAR MkPISpVv[3Srb36gZZN{[Xl? NYfF[XdmUW6qaXLpeIlwdiCxZjDz[ZJwfG:waX6geZB1[WunIHH0JIh2dWGwIGPFVnQh\XiycnXzd4VlKGmwIHj1cYFvKEqDUjDj[YxteyxiSVO1NF0xNjBzzszN M{KwU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7M{K5N|E{Lz5zOUOyPVMyOzxxYU6=
MDCK-Net6 MnTaSpVv[3Srb36gZZN{[Xl? NGPQdlBKdmirYnn0bY9vKG:oIH7vdoVxcW6ncHjybY5mKHWydHHr[UBifCCqdX3hckBPTVRiZYjwdoV{e2WmIHnuJG1FS0tvTnX0OkBk\WyuczygTWM2OD1yLkW2N:69VQ>? NILRVGc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUOyPVMyOyd-MUmzNlk{OTN:L3G+
JAR M1qwcWZ2dmO2aX;uJIF{e2G7 NFr6WY5KdmirYnn0bY9vKG:oIIPldo91d26rbjD1dJRic2ViYYSgbJVu[W5iU1XSWEBmgHC{ZYPz[YQhcW5iSlHSJINmdGy|LDDJR|UxRTBwMEC5OO69VQ>? NWDsbIY5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm2N|IyOTBpPkG5OlMzOTFyPD;hQi=>
JAR NX;WdnNZTnWwY4Tpc44h[XO|YYm= NH3nVm9KdmirYnn0bY9vKG:oIHj1cYFvKFOHUmSg[ZhxemW|c3XkJIlvKEqDUjDj[YxteyxiSVO1NF0xNjByOUVOwG0> NVHEO5VMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm3NVMyODZpPkG5O|E{OTB4PD;hQi=>
JAR MULGeY5kfGmxbjDhd5NigQ>? NYj4Z4dNUW6qaXLpeIlwdiCxZjDbN2hecHmmcn;4fZRzgXC2YX3pcoUh[3KnYYTpcolv\SC|dXzmZZRmKHWydHHr[UBifCCqdX3hckBUTVKWIHX4dJJme3OnZDDpckBpfW2jbjDKRXIh[2WubIOsJGlEPTB;MD6wNFk1|ryP M17kTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7N{KyOVI2Lz5zOUeyNlUzPTxxYU6=
HEK293 NFq0OZNHfW6ldHnvckBie3OjeR?= NGXG[GxFcXOybHHj[Y1mdnRib3[gX2kyOjWfUmTJMVU2KG[{b32gbJVu[W5iU1XSWEB1emGwc3\lZ5Rm\CCrbjDoeY1idiCKRVuyPVMh[2WubIOsJGlEPTB;MD6wNFI2|ryP NVPYUI1tRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCwN|Q4QTNpPkKwNFM1Pzl|PD;hQi=>
JAR MUXGeY5kfGmxbjDhd5NigQ>? NF62TFBKdmirYnn0bY9vKG:oIIPldo91d26rbjD1dJRic2ViYYSgbJVu[W5iU1XSWEBmgHC{ZYPz[YQhcW5iaIXtZY4hUkGUIHPlcIx{NCCLQ{WwQVAvODB7NN88US=> NXnvUXpvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCxN|E5PjRpPkKwNVMyQDZ2PD;hQi=>
JAR MnHVSpVv[3Srb36gZZN{[Xl? NEPWPIVKdmirYnn0bY9vKG:oIHj1cYFvKFOHUmSg[ZhxemW|c3XkJIlvKGi3bXHuJGpCWiClZXzsd{whUUN3ME2wMlAxQTUQvF2= NW[0WHVpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCzO|g{PDdpPkKwN|c5OzR5PD;hQi=>
JAR MkDiSpVv[3Srb36gZZN{[Xl? M2fxWWlvcGmkaYTpc44hd2ZiU1XSWE1u\WSrYYTl[EB{\XKxdH;ubY4hfXC2YXvlJIlvKGi3bXHuJGpCWiClZXzsd{whUUN3ME2wMlAxQTUQvF2= MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODR4MkKxNUc,OjB2NkKyNVE9N2F-
BESM M4H3O2FvfGm2conwZY5we2:vYXygZZN{[Xl? Mn\0PFghcHK| NIno[XlCdnSrdIL5dIFvd3OxbXHsJIFkfGm4aYT5JIFo[Wmwc4SgWJJ6eGGwb4PvcYEh[3K3enmgZY1ie3SrZ3;0[ZMhcW6oZXP0[YQhcW5iQlXTUUBk\WyuczDt[YF{fXKnZDDh[pRmeiB6ODDodpMheG:|dHnu[oVkfGmxbjDifUBJXFNiYYPzZZktKEWFNUC9O:69VQ>? MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODV2N{ixPUc,OjB3NEe4NVk9N2F-
BESM NF7S[25EgXSxdH;4bYNqfHliYYPzZZk> MoDxPFghcHK| NWTJbFE2S3m2b4TvfIlkcXS7IHHnZYlve3RiQlXTUUBk\WyuczDh[pRmeiB6ODDodpMh[nliSGTTJIF{e2G7LDDFR|UxRTF4zszN MljEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjB3NEe4NVkoRjJyNUS3PFE6RC:jPh?=
HEK293 NUflW295TnWwY4Tpc44h[XO|YYm= NILtVXBFcXOybHHj[Y1mdnRib3[gX|NJZSCjc4TlcYl7d2ynIH\yc40hcHWvYX6gdoVkd22kaX7hcpQhTVKJIHPoZY5v\WxiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyxiSVO1NF0{NjIQvF2= MonTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjB4M{e2N|UoRjJyNkO3OlM2RC:jPh?=
HEK293 NFKwT3hHfW6ldHnvckBie3OjeR?= NYDQUG12UW6qaXLpeIlwdiCxZjDz[ZJwfG:waX6gdoV2eHSja3WgZZQhcHWvYX6gV2VTXCCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{NCCLQ{WwQVAvODB|Md88US=> M4DaOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyN{K0NVU{Lz5{MEeyOFE2OzxxYU6=
HEK293 M1rtb2Z2dmO2aX;uJIF{e2G7 NEnwRXZKdmirYnn0bY9vKG:oIGuzTH1{\XKxdH;ubY4hemW3cIThb4Uh[XRiaIXtZY4hW0WUVDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHL5JJNkcW62aXzsZZRqd25iY3;1cpRqdmduIFnDOVA:OC5yMEWy{txO MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTB7M{K3N{c,OjFyOUOyO|M9N2F-
LLC-PK1 NUjXVHFOTnWwY4Tpc44h[XO|YYm= MoLJTY5pcWKrdHnvckBw\iCdM1jdd4Vzd3SxbnnuJJJmfXC2YXvlJIF1KGi3bXHuJJJm[2:vYnnuZY51KFOHUmSg[ZhxemW|c3XkJIlvKEyOQz3QT|Eh[2WubIOgZpkhdGmzdXnkJJNkcW62aXzsZZRqd25iY3;1cpRqdmduIFnDOVA:OC5yMEWwNVLPxE1? NHrs[IE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUOxNFYyOid-MkGzNVA3OTJ:L3G+
HEK293 MVXGeY5kfGmxbjDhd5NigQ>? MVjJcohq[mm2aX;uJI9nKHOncn;0c45qdiC{ZYXweIFs\SCjdDDTSXJVKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMtKEmFNUC9NE4xODVyMUNOwG0> NUH4SJFZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG3N|k6OzVpPkKxO|M6QTN3PD;hQi=>
JAR M1fLRmZ2dmO2aX;uJIF{e2G7 M17E[GlvcGmkaYTpc44hd2ZiaIXtZY4hW0WUVDDlfJBz\XO|ZXSgbY4hUkGUIHPlcIx{KGG|c3Xzd4VlKGG|IIPldo91d26rbjD1dJRic2VuIFnDOVA:OC5yMEm0{txO NEf5RYw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUmxOlQzOSd-MkG5NVY1OjF:L3G+
HEK293 MVLGeY5kfGmxbjDhd5NigQ>? Mlj6TY5pcWKrdHnvckBw\iCqdX3hckBUTVKWLX3l[IlifGWmIIPldo91d26rbjDy[ZVxfGGtZTDpckBJTUt{OUOgZ4VtdHNuIFXDOVA:OC5yMEK3{txO NXLvc|V4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG5Nlc3PDVpPkKxPVI4PjR3PD;hQi=>
CHO MVrGeY5kfGmxbjDhd5NigQ>? MYrJcohq[mm2aX;uJI9nKHKjdDD2c4x1[WenLXfheIVlKEtiY3jhco5mdCB|LkGg[ZhxemW|c3XkJIlvKEOKTzDj[YxteyCkeTDwZZRkcCClbHHtdEBie3OjeTygTWM2OD1zMz6x{txO MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF{MUC5Okc,OjNzMkGwPVY9N2F-
HEK293 MkHSSpVv[3Srb36gZZN{[Xl? NUPINohLPjBibXnudy=> NHrzTXZFcXOybHHj[Y1mdnRib3[gX|NJZVCjcn;4[ZRqdmViZoLvcUBpfW2jbjDy[YNwdWKrbnHueEBUTVKWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiYX\0[ZIhPjBibXnud{whU2l;MD6wNFE1|ryP MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRyM{C4Nkc,OjN2MEOwPFI9N2F-
HEK293 M1Xt[WZ2dmO2aX;uJIF{e2G7 MlK5OlAhdWmwcx?= M3jlPGRqe3CuYXPlcYVvfCCxZjDbN2heWGG{b4jleIlv\SCocn;tJIh2dWGwIILlZ49u[mmwYX70JHNGWlRiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjZoTldkA3OCCvaX7zMEBKSzVyPUCuNFA5Ps7:TR?= NUSzeIJDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO0NFMxQDJpPkKzOFA{ODh{PD;hQi=>
HEK293 MljTSpVv[3Srb36gZZN{[Xl? MX[xNEBucW6| MVXJcohq[mm2aX;uJI9nKFt|SG21MWhVKHWydHHr[UBifCCqdX3hckBUTVKWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNicILlbY5kfWKjdHXkJIZweiBzMDDtbY5{KHC{aX;yJJRwKHO3YoP0doF1\SCjZHTpeIlwdiCvZXHzeZJm\CCjZoTldkA1KG2rboOgZpkhTkyLUGKgZZN{[XluIFvpQVAvODl6zszN M{fGWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NkCyOFQ2Lz5{M{[wNlQ1PTxxYU6=
HEK293 MlrFSpVv[3Srb36gZZN{[Xl? MoP1NVAhdWmwcx?= M2XRUWlvcGmkaYTpc44hd2ZiW{PIYVUuUFRidYD0ZYtmKGG2IHj1cYFvKFOHUmSg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDwdoVqdmO3YnH0[YQh\m:{IEGwJI1qdnNicILpc5IhfG9ic4Xid5Rz[XSnIHHk[Il1cW:wIH3lZZN2emWmIHHmeIVzKDRibXnud{BjgSCITFnQVkBie3OjeTygTWM2OD1yLkK4NVg1|ryP NWP6bZU6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO2NFI1PDVpPkKzOlAzPDR3PD;hQi=>
HEK293 NIi3WFlHfW6ldHnvckBie3OjeR?= MU[xNEBucW6| M3vPNmlvcGmkaYTpc44hd2ZiW{PIYY5wemWyaX7ldIhzcW6nIIXweIFs\SCjdDDoeY1idiCQRWSg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDwdoVqdmO3YnH0[YQh\m:{IEGwJI1qdnNicILpc5IhfG9ic4Xid5Rz[XSnIHHk[Il1cW:wIH3lZZN2emWmIHHmeIVzKDRibXnud{BjgSCITFnQVkBie3OjeTygT4k:OS5|OUVOwG0> MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzZyMkS0OUc,OjN4MEK0OFU9N2F-
HEK293 M1viOWZ2dmO2aX;uJIF{e2G7 MVmxNEBucW6| NY\Mc4U{UW6qaXLpeIlwdiCxZjDbN2he\G:yYX3pcoUhfXC2YXvlJIF1KGi3bXHuJGRCXCCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{KHC{ZXnuZ5Vj[XSnZDDmc5IhOTBibXnud{BxemmxcjD0c{B{fWK|dILheIUh[WSmaYTpc44hdWWjc4Xy[YQh[W[2ZYKgOEBucW6|IHL5JGZNUVCUIHHzd4F6NCCNaU2zMlc3PM7:TR?= Ml\hQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN4MEK0OFUoRjJ|NkCyOFQ2RC:jPh?=
HEK293 MlLpSpVv[3Srb36gZZN{[Xl? MUSxNEBucW6| NI\weWdKdmirYnn0bY9vKG:oIGuzTH1vd3KncHnu[ZBpemmwZTD1dJRic2ViYYSgbJVu[W5iTlXUJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgdJJmcW6ldXLheIVlKG[xcjCxNEBucW6|IIDybY9zKHSxIIP1ZpN1emG2ZTDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB2IH3pcpMh[nliRlzJVHIh[XO|YYmsJGlEPTB;Nj6zNFk2P87:TR?= MlzaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN4MEK0OFUoRjJ|NkCyOFQ2RC:jPh?=
HEK293 MW\GeY5kfGmxbjDhd5NigQ>? MVKxNEBucW6| NHzYVpJKdmirYnn0bY9vKG:oIGuzTH1ld3CjbXnu[UB2eHSja3WgZZQhcHWvYX6gSGFVKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMheHKnaX7jeYJifGWmIH\vdkAyOCCvaX7zJJBzcW:{IITvJJN2[nO2cnH0[UBi\GSrdHnvckBu\WG|dYLl[EBi\nSncjC0JI1qdnNiYomgSmxKWFJiYYPzZZktKEmFNUC9PU4yOjBzMd88US=> MnfhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN4MEK0OFUoRjJ|NkCyOFQ2RC:jPh?=
HEK293 M1\2emZ2dmO2aX;uJIF{e2G7 Ml33SIl{eGyjY3Xt[Y51KG:oIGuzTH1qdWmycnHtbY4h\nKxbTDoeY1idiC{ZXPvcYJqdmGwdDDTSXJVKG:4ZYKt[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczygTWM2OD1yLkCwO|LPxE1? NH2xSlI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NECxNlE5OSd-MkSwNVIyQDF:L3G+
HEK293 MWjGeY5kfGmxbjDhd5NigQ>? MV:xOUBucW6| NH3rOpNKdmirYnn0bY9vKG:oIIPldo91d26rbjDy[ZVxfGGtZTDheEBpfW2jbjDTSXJVKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[W[2ZYKgNVUhdWmwczDifUBndHWxcnXzZ4Vv[2VibnX1do91emGwc33peJRmeiC2cnHud5BwenSncjDhd5NigSxiSVO1NF0xNjF3zszN M{DIVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUe0N|QxLz5{NEm3OFM1ODxxYU6=
HEK293 NWXHd203TnWwY4Tpc44h[XO|YYm= MlzlNVUhdWmwcx?= NXLlb4lNUW6qaXLpeIlwdiCxZjDuc5JmeGmwZYDodolv\SC{ZYXweIFs\SCjdDDoeY1idiCQRWSg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDh[pRmeiBzNTDtbY5{KGK7IH\seY9z\XOlZX7j[UBv\XW{b4TyZY5{dWm2dHXyJJRz[W6|cH;yeIVzKGG|c3H5MEBKSzVyPUSuOFHPxE1? Mk\IQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7N{SzOFAoRjJ2OUe0N|QxRC:jPh?=
HEK293 MUfGeY5kfGmxbjDhd5NigQ>? MUOxOUBucW6| M2rpRWlvcGmkaYTpc44hd2ZiRFGgdoV2eHSja3WgZZQhcHWvYX6gSGFVKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[W[2ZYKgNVUhdWmwczDifUBndHWxcnXzZ4Vv[2VibnX1do91emGwc33peJRmeiC2cnHud5BwenSncjDhd5NigSxiSVO1NF0yQC52zszN NF[2Zmk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEm3OFM1OCd-MkS5O|Q{PDB:L3G+
HEK293 NELpNWlHfW6ldHnvckBie3OjeR?= MnnyNVUhdWmwcx?= NF31[FNKdmirYnn0bY9vKG:oIHj1cYFvKFOHUmSg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDheEBqdmO3YnH0[YQh\m:{IEG1JI1qdnNiYomgcoV2em:2cnHud41qfHSncjDy[ZVxfGGtZTDhd5NigSxiSVO1NF0xNjF3zszN MkL6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{MkG2OVYoRjJ3MkKxOlU3RC:jPh?=
HEK293 MlPnSpVv[3Srb36gZZN{[Xl? MY[xOUBucW6| M3KxU2lvcGmkaYTpc44hd2ZiaIXtZY4hVkWWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiYYSgbY5kfWKjdHXkJIZweiBzNTDtbY5{KGK7IH7leZJwfHKjboPtbZR1\XJicnX1dJRic2ViYYPzZZktKEmFNUC9OE41Oc7:TR?= NWPYOG93RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWyNlE3PTZpPkK1NlIyPjV4PD;hQi=>
HEK293 NUn5TnB[TnWwY4Tpc44h[XO|YYm= NXKxeJA3OTVibXnudy=> M2eySWlvcGmkaYTpc44hd2ZiaIXtZY4hTEGWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiYYSgbY5kfWKjdHXkJIZweiBzNTDtbY5{KGK7IH7leZJwfHKjboPtbZR1\XJicnX1dJRic2ViYYPzZZktKEmFNUC9NVgvPM7:TR?= M3PKV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MkKxOlU3Lz5{NUKyNVY2PjxxYU6=
HEK293 MW\GeY5kfGmxbjDhd5NigQ>? M4TI[mlvcGmkaYTpc44hd2Zib3[gbJVu[W5iVGLFT|Eh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4hidm6nbDDjeZJz\W62czygTWM2OD1zNN88US=> MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjV6OEC0OUc,OjZ3OEiwOFU9N2F-
tsA201 MnnWSpVv[3Srb36gZZN{[Xl? MoLPTY5pcWKrdHnvckBw\iCxZjDoeY1idiCWUlXLNUBmgHC{ZYPz[YQhcW5idIPBNlAyKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDjbIFvdmWuIHP1dpJmdnS|LDDJR|UxRTF7zszN MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjV6OEC0OUc,OjZ3OEiwOFU9N2F-
OHS-50 MoLBdWhVWyCjc4PhfS=> MWDxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhV0iVLUWwJINmdGy| M2HlSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
MG 63 (6-TG R) NWjrNG1meUiWUzDhd5NigQ>? MWrxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVUdiNkOgLFYuXEdiUjmgZ4VtdHN? M4LKZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
RD M3\wUmFvfGm4aYLhcEBie3OjeR?= NGfiS2c2KG2rboO= Mo\YRY51cX[rcnHsJIFkfGm4aYT5JIFo[Wmwc4SgSY51\XKxdnnyeZMhTDZ6IGXTM2t[NzF2LUG4PVU{KGmwZnXjeIVlKGmwIHj1cYFvKFKGIHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4Yhfmm{dYOtbY5lfWOnZDDjfZRweGG2aHnjJIVn\mWldDDpcoN2[mG2ZXSg[o9zKDVibXnud{B2dmSncjDzbIFscW6pIHPvcoRqfGmxbjDhcoQhdWWjc4Xy[YQh[W[2ZYKgN{Bl[Xm|IHL5JI5mfXS{YXygdoVlKGS7ZT3iZZNm\CCyaH;0c41mfHKrYzDt[ZRpNCCHQ{WwQVHPxE1? NHm2bGQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEmxNlk1PCd-M{C5NVI6PDR:L3G+
RD MUXDfZRwfG:6aXPpeJkh[XO|YYm= Ml7zN{Bl[Xm| NX7UbY1qS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hWkRiY3XscJMh[W[2ZYKgN{Bl[Xm|IHL5JI5mfXS{YXygdoVlKGS7ZT3iZZNm\CCyaH;0c41mfHKrYzDt[ZRpd2RuIFPDOVA:OTFwOd88US=> MoDWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB7MUK5OFQoRjNyOUGyPVQ1RC:jPh?=
Huh7 NHLHXm5CdnSrdnnyZYwh[XO|YYm= MmTYRY51cX[rcnHsJIFkfGm4aYT5JIFo[Wmwc4SgSGVPXjJiaX7m[YN1\WRiaX6gbJVu[W5iSIXoO{Bk\WyuczDifUByWlRvUFPSJIFv[Wy7c3nzMEBKSzVyPUCuN|jPxE1? NHfnfIY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUGyPFQ1Pyd-M{GxNlg1PDd:L3G+
In vivo Fluoxetine treatment also reverses the deficit in escape latency observed in animals exposed to inescapable shock in adult male Sprague–Dawley rats. [1] Fluoxetine combined with Olanzapine produces robust, sustained increases of extracellular levels of dopamine ([DA](ex)) and norepinephrine ([NE](ex)) up to 361% and 272% of the baseline, respectively, which are significantly greater than either drug alone. [5]

Protocol (from reference)

Solubility (25°C)

In vitro

DMSO 69 mg/mL
(199.54 mM)
Water 4 mg/mL
(11.56 mM)
Ethanol '69 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 345.79
Formula

C17H18F3NO.HCl

CAS No. 56296-78-7
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04676139 Recruiting Drug: Fluoxetine|Drug: Placebo Nocturnal Enuresis Mansoura University July 1 2020 Phase 3
NCT01615055 Withdrawn Drug: Fluoxetine|Other: Placebo Cognitive Dysfunction University of California Los Angeles|City of Hope Medical Center June 2018 Early Phase 1
NCT03390933 Recruiting Drug: Fluoxetine Depression|Hemodialysis-Induced Symptom MetroHealth Medical Center March 1 2018 Phase 4
NCT02767999 Recruiting Drug: Fluoxetine|Drug: Placebo|Radiation: fMRI Stroke University Hospital Toulouse February 27 2017 Phase 4
NCT03476525 Recruiting Drug: Fluoxetine Obesity Morbid Norwegian University of Science and Technology|St. Olavs Hospital|Volvat Medisinsk Senter Stokkan|Namsos Hospital|Alesund Hospital November 2 2016 --
NCT02063425 Terminated Drug: Fluoxetine|Drug: Placebo of fluoxetine Cerebral Infarction Centre Hospitalier St Anne February 2014 Not Applicable

(data from https://clinicaltrials.gov, updated on 2021-09-06)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Fluoxetine (Lilly 110140) HCl | Fluoxetine (Lilly 110140) HCl supplier | purchase Fluoxetine (Lilly 110140) HCl | Fluoxetine (Lilly 110140) HCl cost | Fluoxetine (Lilly 110140) HCl manufacturer | order Fluoxetine (Lilly 110140) HCl | Fluoxetine (Lilly 110140) HCl distributor